Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor–T Cell Therapy for Hematological Malignant Neoplasms
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.8161
Abstract: Key Points Question What is the proportion of Black participants enrolled in pivotal clinical trials supporting US Food and Drug Administration approval of chimeric antigen receptor–T cell (CAR-T) therapy for hematological malignant neoplasms? Findings In… read more here.
Keywords: clinical trials; food drug; malignant neoplasms; black participants ... See more keywords
Socioeconomic Status and Overall Survival Among Patients With Hematological Malignant Neoplasms
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.1112
Abstract: Key Points Question Has the socioeconomic gap in survival for patients with hematological malignant neoplasms changed in recent years? Findings This cohort study including 5677 patients with hematological malignant neoplasms in Denmark found no significant… read more here.
Keywords: socioeconomic status; hematological malignant; survival; malignant neoplasms ... See more keywords